{"id":2230,"date":"2022-05-19T00:00:00","date_gmt":"2022-05-19T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2230"},"modified":"2022-05-19T00:00:00","modified_gmt":"2022-05-19T00:00:00","slug":"centogene-se-presentara-en-la-conferencia-global-de-inversion-hc-wainwright","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/es\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\/","title":{"rendered":"CENTOGENE se presentar\u00e1 en la Conferencia Global de Inversi\u00f3n HC Wainwright"},"content":{"rendered":"<p><strong>CAMBRIDGE, Massachusetts y ROSTOCK, Alemania, y BERL\u00cdN, 19 de mayo de 2022 (GLOBE NEWSWIRE) \u2013 <\/strong>Centogene NV (Nasdaq: CNTG), el socio de ciencias biol\u00f3gicas de biodatos esenciales en etapa comercial para enfermedades raras y neurodegenerativas, anunci\u00f3 hoy que la gerencia de la empresa se presentar\u00e1 en la sesi\u00f3n virtual de la Conferencia de inversi\u00f3n global HC Wainwright que se llevar\u00e1 a cabo del 23 al 26 de mayo de 2022, e invita a los inversores a participar a trav\u00e9s de reuniones virtuales individuales.<\/p>\n<p>Consulte detalles adicionales a continuaci\u00f3n:<\/p>\n<h3>Conferencia de Inversi\u00f3n Global HC Wainwright (Conferencia H\u00edbrida)<\/h3>\n<h4>Ponentes:<\/h4>\n<p>Kim Stratton, directora ejecutiva de Centogene NV.<br \/> Miguel Coego \u2013 Director financiero (ai) de Centogene NV.<\/p>\n<h4>Formato:<\/h4>\n<p>Presentaci\u00f3n de la empresa y reuniones individuales<\/p>\n<h4>Transmisi\u00f3n web:<\/h4>\n<p>La grabaci\u00f3n* estar\u00e1 disponible a partir del martes 24 de mayo de 2022 a las 7:00 a. m., hora del Este, a trav\u00e9s del sitio web de relaciones con inversores de CENTOGENE en <a href=\"https:\/\/centogene.gcs-web.com\/events\/event-details\/hc-wainwright-global-investment-conference\" target=\"_blank\" title=\"Grabaci\u00f3n\">https:\/\/centogene.gcs-web.com\/events\/event-details\/hc-wainwright-global-investment-conference<\/a><\/p>\n<p>Enlace de registro: <a href=\"https:\/\/hcwevents.com\/globalconference\/\" title=\"Registro\">https:\/\/hcwevents.com\/globalconference\/<\/a><\/p>\n<p class=\"t3m-small\">*Habr\u00e1 una repetici\u00f3n disponible durante 90 d\u00edas despu\u00e9s de la presentaci\u00f3n.<\/p>\n<p>Comun\u00edquese con su representante en HC Wainwright para programar una reuni\u00f3n virtual individual con CENTOGENE durante la conferencia. Para obtener informaci\u00f3n sobre la Conferencia Global de Inversi\u00f3n de HC Wainwright, consulte el sitio web del evento.<a href=\"https:\/\/hcwevents.com\/globalconference\/\" title=\"Conferencia mundial\">https:\/\/hcwevents.com\/globalconference\/<\/a>).<\/p>\n<h3>Acerca de CENTOGENE<\/h3>\n<p>CENTOGENE se dedica al diagn\u00f3stico y la investigaci\u00f3n de enfermedades raras, transformando datos cl\u00ednicos, gen\u00e9ticos y multi\u00f3micos del mundo real para diagnosticar, comprender y tratar enfermedades raras. Nuestro objetivo es racionalizar las decisiones terap\u00e9uticas y acelerar el desarrollo de nuevos medicamentos hu\u00e9rfanos mediante nuestro amplio conocimiento y datos sobre enfermedades raras. CENTOGENE ha desarrollado una plataforma global propia para enfermedades raras, basada en nuestro repositorio de datos del mundo real de m\u00e1s de 650.000 personas de m\u00e1s de 120 pa\u00edses.<\/p>\n<p>La plataforma de la Compa\u00f1\u00eda incluye datos epidemiol\u00f3gicos, fenot\u00edpicos y gen\u00e9ticos que reflejan una poblaci\u00f3n global, as\u00ed como un biobanco de muestras de sangre y cultivos celulares de pacientes. CENTOGENE considera que esta es la \u00fanica plataforma centrada en el an\u00e1lisis exhaustivo de datos multinivel para mejorar la comprensi\u00f3n de las enfermedades hereditarias raras. Permite una mejor identificaci\u00f3n y estratificaci\u00f3n de los pacientes y sus enfermedades subyacentes para facilitar y acelerar el descubrimiento, el desarrollo y el acceso a medicamentos hu\u00e9rfanos. Al 31 de diciembre de 2021, la Compa\u00f1\u00eda colaboraba con m\u00e1s de 30 socios farmac\u00e9uticos.<\/p>\n<p>S\u00edguenos en <a href=\"https:\/\/de.linkedin.com\/company\/centogene\" target=\"_blank\" title=\"Enlace a LinkedIn\">LinkedIn<\/a><\/p>\n<h3>Declaraciones prospectivas<\/h3>\n<p>Este comunicado de prensa contiene \u201cdeclaraciones prospectivas\u201d en el sentido de las leyes federales de valores de EE. UU. Las declaraciones aqu\u00ed contenidas que no sean claramente de naturaleza hist\u00f3rica se consideran prospectivas, y las palabras \u201canticipar\u201d, \u201ccreer\u201d, \u201ccontin\u00faa\u201d, \u201cesperar\u201d, \u201cestimar\u201d, \u201cpretender\u201d, \u201cproyectar\u201d y expresiones similares, as\u00ed como verbos en futuro o condicional como \u201cvoluntad\u201d, \u201cser\u00eda\u201d, \u201cdeber\u00eda\u201d, \u201cpodr\u00eda\u201d, \u201cpodr\u00eda\u201d, \u201cpuede\u201d y \u201cpuede\u201d, generalmente se utilizan para identificar declaraciones prospectivas. Dichas declaraciones prospectivas implican riesgos conocidos y desconocidos, incertidumbres y otros factores importantes que podr\u00edan causar que los resultados, el rendimiento o los logros reales de CENTOGENE difieran sustancialmente de cualquier resultado, rendimiento o logro futuro, expresado o impl\u00edcito en las declaraciones prospectivas. Tales riesgos e incertidumbres incluyen, entre otros, condiciones econ\u00f3micas y geopol\u00edticas negativas e inestabilidad y volatilidad en los mercados financieros mundiales, posibles cambios en la legislaci\u00f3n actual y propuesta, regulaciones y pol\u00edticas gubernamentales, presiones de la creciente competencia y consolidaci\u00f3n en nuestra industria, el gasto y la incertidumbre de la aprobaci\u00f3n regulatoria, incluyendo la de la Administraci\u00f3n de Alimentos y Medicamentos de los Estados Unidos, nuestra dependencia de terceros y socios de colaboraci\u00f3n, incluyendo nuestra capacidad para gestionar el crecimiento y entrar en nuevas relaciones con clientes, nuestra dependencia de la industria de enfermedades raras, nuestra capacidad para gestionar la expansi\u00f3n internacional, nuestra dependencia de personal clave, nuestra dependencia de la protecci\u00f3n de la propiedad intelectual, fluctuaciones de nuestros resultados operativos debido al efecto de los tipos de cambio, nuestra capacidad para optimizar el uso de efectivo, nuestro requerimiento de financiamiento adicional u otros factores. Para obtener m\u00e1s informaci\u00f3n sobre los riesgos e incertidumbres que podr\u00edan causar que los resultados reales difieran de los expresados en estas declaraciones prospectivas, as\u00ed como sobre los riesgos relacionados con el negocio de CENTOGENE en general, consulte los factores de riesgo de CENTOGENE establecidos en el Formulario 20-F presentado el 31 de marzo de 2022 ante la Comisi\u00f3n de Bolsa y Valores (la &quot;SEC&quot;) y en los documentos presentados posteriormente ante la SEC. Las declaraciones prospectivas contenidas en este comunicado de prensa se refieren \u00fanicamente a la fecha del presente, y CENTOGENE renuncia espec\u00edficamente a cualquier obligaci\u00f3n de actualizarlas, ya sea como resultado de nueva informaci\u00f3n, eventos futuros o cualquier otra causa.<\/p>\n<h5>Contacto de prensa: &nbsp;<\/h5>\n<p>CENTOGENE<\/p>\n<p>Lennart Streibel<br \/> Relaciones con los inversores<br \/> <a href=\"mailto:investor.relations@centogene.com\" title=\"Escribe un correo electr\u00f3nico\">relacionesconinversores@centogene.com <\/a><\/p>\n<p>Ben Legg<br \/> Comunicaciones corporativas&nbsp;<br \/> <a href=\"mailto:press@centogene.com\" title=\"Escribe un correo electr\u00f3nico\">presione(at)centogene(dot)com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, May 19, 2022 (GLOBE NEWSWIRE) \u2013 Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2230","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE to Present at the H.C. Wainwright Global Investment Conference | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/es\/centogene-se-presentara-en-la-conferencia-global-de-inversion-hc-wainwright\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE to Present at the H.C. Wainwright Global Investment Conference | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, May 19, 2022 (GLOBE NEWSWIRE) \u2013 Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/es\/centogene-se-presentara-en-la-conferencia-global-de-inversion-hc-wainwright\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-19T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE to Present at the H.C. Wainwright Global Investment Conference\",\"datePublished\":\"2022-05-19T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\\\/\"},\"wordCount\":703,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\\\/\",\"name\":\"CENTOGENE to Present at the H.C. Wainwright Global Investment Conference | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2022-05-19T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE to Present at the H.C. Wainwright Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/es\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE presentar\u00e1 en la Conferencia Global de Inversiones de HC Wainwright | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/es\/centogene-se-presentara-en-la-conferencia-global-de-inversion-hc-wainwright\/","og_locale":"es_ES","og_type":"article","og_title":"CENTOGENE to Present at the H.C. Wainwright Global Investment Conference | CENTOGENE","og_description":"CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, May 19, 2022 (GLOBE NEWSWIRE) \u2013 Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential [&hellip;]","og_url":"https:\/\/www.centogene.com\/es\/centogene-se-presentara-en-la-conferencia-global-de-inversion-hc-wainwright\/","og_site_name":"CENTOGENE","article_published_time":"2022-05-19T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admincg","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE to Present at the H.C. Wainwright Global Investment Conference","datePublished":"2022-05-19T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\/"},"wordCount":703,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\/","url":"https:\/\/www.centogene.com\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\/","name":"CENTOGENE presentar\u00e1 en la Conferencia Global de Inversiones de HC Wainwright | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2022-05-19T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-to-present-at-the-hc-wainwright-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE to Present at the H.C. Wainwright Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Impulsar la medicina de precisi\u00f3n","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"administrador","url":"https:\/\/www.centogene.com\/es\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/comments?post=2230"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2230\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/media?parent=2230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/categories?post=2230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/tags?post=2230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}